Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Zahavi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Progress in Molecular Biology and Translational Science|August 7, 2019
Tumor mechanisms of resistance to immune attackDavid J Zahavi, Louis M Weiner
International Journal of Molecular Sciences|January 10, 2019
Targeting Multiple Receptors to Increase Checkpoint Blockade EfficacyDavid J Zahavi, Louis M Weiner
Seminars in Cancer Biology|December 24, 2019
Overcoming malignant cell-based mechanisms of resistance to immune checkpoint blockade antibodiesReham Ajina, David J Zahavi, Yong-Wei Zhang, et al.
Human Pathology|April 13, 2016
The utility of STAT6 and ALDH1 expression in the differential diagnosis of solitary fibrous tumor versus prostate-specific stromal neoplasmsGunes Guner, Justin A Bishop, Stephania M Bezerra, et al.
Cancer Immunology Research|December 20, 2018
A Mechanism of Resistance to Antibody-Targeted Immune AttackDalal S Aldeghaither, David J Zahavi, Joseph C Murray, et al.
Virchows Archiv : an International Journal of Pathology|June 9, 2016
For staining of ALK protein, the novel D5F3 antibody demonstrates superior overall performance in terms of intensity and extent of staining in comparison to the currently used ALK1 antibodyDiana Taheri, David J Zahavi, Maria Del Carmen Rodriguez, et al.
Cancer Biology & Therapy|October 25, 2023
Antibody dependent cell-mediated cytotoxicity selection pressure induces diverse mechanisms of resistanceDavid J Zahavi, Rossin Erbe, Yong-Wei Zhang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Progress in Molecular Biology and Translational Science|August 7, 2019
Tumor mechanisms of resistance to immune attackDavid J Zahavi, Louis M Weiner
International Journal of Molecular Sciences|January 10, 2019
Targeting Multiple Receptors to Increase Checkpoint Blockade EfficacyDavid J Zahavi, Louis M Weiner
Seminars in Cancer Biology|December 24, 2019
Overcoming malignant cell-based mechanisms of resistance to immune checkpoint blockade antibodiesReham Ajina, David J Zahavi, Yong-Wei Zhang, et al.
Human Pathology|April 13, 2016
The utility of STAT6 and ALDH1 expression in the differential diagnosis of solitary fibrous tumor versus prostate-specific stromal neoplasmsGunes Guner, Justin A Bishop, Stephania M Bezerra, et al.
Cancer Immunology Research|December 20, 2018
A Mechanism of Resistance to Antibody-Targeted Immune AttackDalal S Aldeghaither, David J Zahavi, Joseph C Murray, et al.
Virchows Archiv : an International Journal of Pathology|June 9, 2016
For staining of ALK protein, the novel D5F3 antibody demonstrates superior overall performance in terms of intensity and extent of staining in comparison to the currently used ALK1 antibodyDiana Taheri, David J Zahavi, Maria Del Carmen Rodriguez, et al.
Cancer Biology & Therapy|October 25, 2023
Antibody dependent cell-mediated cytotoxicity selection pressure induces diverse mechanisms of resistanceDavid J Zahavi, Rossin Erbe, Yong-Wei Zhang, et al.
Pageof 1